Source:http://linkedlifedata.com/resource/pubmed/id/19117856
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-1-1
|
pubmed:abstractText |
Disease management for mucopolysaccharidosis type I has been inconsistent because of disease rarity (approximately 1 case per 100,000 live births), phenotypic heterogeneity, and limited therapeutic options. The availability of hematopoietic stem cell transplantation and the recent introduction of enzyme replacement therapy for mucopolysaccharidosis I necessitate the establishment of system-specific management guidelines for this condition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1098-4275
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-29
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Mucopolysaccharidosis I: management and treatment guidelines.
|
pubmed:affiliation |
Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. muenzer@med.unc.edu
|
pubmed:publicationType |
Journal Article,
Practice Guideline
|